Fang-Ting Kuo is a Senior Manager in Statistical Programming at Pfizer, where she leverages over a decade of experience to lead programming activities for pivotal oncology clinical studies. Since the acquisition of Seagen Inc. by Pfizer in December 2023, Fang-Ting has played a crucial role...
Fang-Ting Kuo is a Senior Manager in Statistical Programming at Pfizer, where she leverages over a decade of experience to lead programming activities for pivotal oncology clinical studies. Since the acquisition of Seagen Inc. by Pfizer in December 2023, Fang-Ting has played a crucial role in integrating programming efforts across multiple oncology projects, ensuring that high-quality outputs are delivered on time. Her expertise in developing and validating CDISC-compliant datasets, specifications, and define documents is instrumental in supporting regulatory submissions, including the preparation of comprehensive data packages and integrated summaries of safety (ISS).
Fang-Ting's proficiency in SAS programming and her deep understanding of statistical methodologies enable her to navigate complex datasets with ease, ensuring compliance with industry standards. Her leadership extends beyond technical skills; she excels in managing teams in fast-paced environments, fostering collaboration, and driving efficiency to meet project milestones. Her extensive background in the pharmaceutical industry, particularly in oncology, equips her with the insights needed to address the unique challenges of this therapeutic area.
In addition to her programming acumen, Fang-Ting is well-versed in bioresearch monitoring (BIMO) activities, further enhancing her capability to oversee comprehensive data management processes. Her commitment to producing high-quality outputs, combined with her organizational skills, positions her as a vital asset to Pfizer's mission of advancing innovative therapies for cancer treatment. As she continues to lead critical projects, Fang-Ting remains dedicated to enhancing the standards of statistical programming and contributing to the success of clinical research initiatives.
